A case study of a patient with metastatic breast cancer. The case will review the application of current guidelines and expert recommendations in the management of the patient, considering regional variations in practice.
Integrate Clinical Guidelines and Best Practices for Metastatic Breast Cancer Read More »
We are pleased to present an insightful case study on managing the adverse effects associated with breast cancer treatment. This case study is presented by our esteemed Key Opinion Leader (KOL), Dr. Wendy Chan, a renowned expert in oncology and patient care. Dr. Chan will delve into the details of a patient’s journey, focusing on practical strategies to manage treatment-related side effects while maintaining the patient’s quality of life.
Breast Cancer First-line Treatment with CDK4/6 Inhibitor Read More »
Dr. Dhanusha Sabanathan discussed the importance of risk-adapted treatment strategies for early breast cancer.
Promote Risk-Adapted Treatment Strategies for Early Breast Cancer Read More »
Professor Hilary Martin discusses HR+ and HER2- metastatic breast cancer
HR+ and HER2- Metastatic Breast Cancer Read More »
Dr. Nick Zdenkowski discusses a case of early-stage, high-risk breast cancer, detailing the patient’s diagnosis, treatment plan, and outcomes.
Early stage high risk ER+/HER2- Breast Cancer Read More »
Dr. Dhanusha Sabanathan, a medical oncologist from Sydney, presents cases of metastatic breast cancer, highlighting the effectiveness of the latest medications in treating metaplastic triple-negative breast cancer with minimal side effects.
Dr. Sabanathan Case Study Read More »
This site is only for use by healthcare professionals.
By continuing to view this site you are confirming that you are a healthcare professional.
